Israel - English - Ministry of Health

tzamal bio-pharma ltd - candesartan cilexetil - tablets - candesartan cilexetil 4 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Israel - English - Ministry of Health

tzamal bio-pharma ltd - candesartan cilexetil - tablets - candesartan cilexetil 8 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Israel - English - Ministry of Health

tzamal bio-pharma ltd - candesartan cilexetil - tablets - candesartan cilexetil 16 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

astrazeneca pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains candesartan cilexetil 8,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

astrazeneca pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains candesartan cilexetil 16 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

astrazeneca pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains candesartan cilexetil 16,0 mg hydrochlorothiazide 12,5 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

astrazeneca pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains candesartan cilexetil 32,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

astrazeneca pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains candesartan cilexetil 32,0 mg hydrochlorothiazide 12,5 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

astrazeneca pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains candesartan cilexetil 32,0 mg hydrochlorothiazide 25,0 mg

United States - English - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx) - atacand is indicated for the treatment of hypertension in adults and in children 1 to <17 years of age, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous an